TrialFrontiers in immunology2021

Safety and Efficacy of Fecal Microbiota Transplantation for Grade IV Steroid Refractory GI-GvHD Patients: Interim Results From FMT2017002 Trial.

Ye Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.